Retroperitoneal lymph node dissection (RPLND) is an effective procedure to treat testicular cancer as it is usually the first lymph node testicular cancer spreads. However, surgical complications of RPLND make it a debatable treatment compared to chemotherapy. RPLND results in 30 to 36% of cases developing retrograde ejaculation, causing semen enters the bladder

Cystectomy and their associated lymph node removal in bladder cancer also pose significant complications, ranging from 30 to 64% due to the complex anatomy of this region. Researchers observed highly trained surgeons in a 12 lymph node dissection, and only 73% of surgeons successfully dissected all 12 lymph nodes.